Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil T Darras

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Neurology|December 19, 2024
Exome and Genome Sequencing to Diagnose the Genetic Basis of Neonatal Hypotonia: An International Consortium StudySarah U Morton, Gregory Costain, Courtney E French, et al.
Neurology|January 13, 2025
Safety and Efficacy of IV Onasemnogene Abeparvovec for Pediatric Patients With Spinal Muscular Atrophy: The Phase 3b SMART StudyHugh J McMillan, Giovanni Baranello, Michelle A Farrar, et al.
Nature Medicine|December 8, 2025
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trialJennifer M Kwon, Francina Munell, Laure Le Goff, et al.
Journal of Human Genetics|October 7, 2016
The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United StatesHemakumar M Reddy, Kyung-Ah Cho, Monkol Lek, et al.
Neuromuscular Disorders : NMD|October 30, 2016
Developmental milestones in type I spinal muscular atrophyRoberto De Sanctis, Giorgia Coratti, Amy Pasternak, et al.
Nature Medicine|January 28, 2026
Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trialJennifer M Kwon, Francina Munell, Laure Le Goff, et al.
Muscle & Nerve|April 8, 2015
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophyJacqueline Montes, Allan M Glanzman, Elena S Mazzone, et al.
Neurology. Clinical Practice|September 3, 2021
Nusinersen Treatment in Adults With Spinal Muscular AtrophyTina Duong, Connie Wolford, Michael P McDermott, et al.
Journal of Neuromuscular Diseases|June 6, 2018
Evaluator Training and Reliability for SMA Global Nusinersen Trials1Allan M Glanzman, Elena S Mazzone, Sally Dunaway Young, et al.
Journal of Neuromuscular Diseases|March 13, 2023
Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG)Richard S Finkel, Basil T Darras, Jerry R Mendell, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Neurology|December 19, 2024
Exome and Genome Sequencing to Diagnose the Genetic Basis of Neonatal Hypotonia: An International Consortium StudySarah U Morton, Gregory Costain, Courtney E French, et al.
Neurology|January 13, 2025
Safety and Efficacy of IV Onasemnogene Abeparvovec for Pediatric Patients With Spinal Muscular Atrophy: The Phase 3b SMART StudyHugh J McMillan, Giovanni Baranello, Michelle A Farrar, et al.
Nature Medicine|December 8, 2025
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trialJennifer M Kwon, Francina Munell, Laure Le Goff, et al.
Journal of Human Genetics|October 7, 2016
The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United StatesHemakumar M Reddy, Kyung-Ah Cho, Monkol Lek, et al.
Neuromuscular Disorders : NMD|October 30, 2016
Developmental milestones in type I spinal muscular atrophyRoberto De Sanctis, Giorgia Coratti, Amy Pasternak, et al.
Nature Medicine|January 28, 2026
Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trialJennifer M Kwon, Francina Munell, Laure Le Goff, et al.
Muscle & Nerve|April 8, 2015
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophyJacqueline Montes, Allan M Glanzman, Elena S Mazzone, et al.
Neurology. Clinical Practice|September 3, 2021
Nusinersen Treatment in Adults With Spinal Muscular AtrophyTina Duong, Connie Wolford, Michael P McDermott, et al.
Journal of Neuromuscular Diseases|June 6, 2018
Evaluator Training and Reliability for SMA Global Nusinersen Trials1Allan M Glanzman, Elena S Mazzone, Sally Dunaway Young, et al.
Journal of Neuromuscular Diseases|March 13, 2023
Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG)Richard S Finkel, Basil T Darras, Jerry R Mendell, et al.
Pageof 23